Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Learn what questions to ask a financial advisor as a new investor. Empower yourself with the right information for success.
27,223 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Investors flooded crypto funds with $858M in inflows as lawmakers push a clarity-focused framework for stablecoins. T...
Fermi’s stock jump today highlights how earnings, project milestones, and strategic pivots shape appetite for AI infr...
On a day when market indexes drift lower, a single retailer can move the needle while tech breakthroughs push a diffe...
Mortgage REITs like AGNC regularly issue new shares to manage leverage and fund income opportunities. This article ex...
UnitedHealth Group has climbed toward its 52-week high, signaling strong investor interest. This article breaks down ...
Choosing a broad-market ETF can feel like splitting hairs. This guide compares VTI and SCHB on cost, exposure, and re...
Caterpillar has emerged as a heavyweight in the Dow, powered by AI-driven infrastructure demand and mining activity. ...
A major stake sale in Albertsons by a large hedge fund sparks questions about what insiders know and how it affects t...
A major biotech-focused fund recently exited a large Nuvalent position, sparking questions about fund flows and stock...
Investors eye defense names as budget cycles shape returns. This guide compares Lockheed Martin and RTX, breaking dow...
The tech hand over fist craze can pull even careful investors into hype. This article lays out a practical plan: choo...